Plasma Cystatin C and Acute Kidney Injury

NCT01652755 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2012-08-06

No results posted yet for this study

Summary

To evaluate the utility of plasma cystatin C(pCysC) as a predictive and diagnostic marker of acute kidney injury(AKI) in patients undergone cardiopulmonary bypass surgery.

Conditions

Sponsors & Collaborators

  • Jinhua Central Hospital

    lead OTHER

Principal Investigators

  • Hongying Ni, MM · Jinhua Municipal Central Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01652755 on ClinicalTrials.gov